Tian Guanxun | Department Of Toxicology School Of Veterinary Medicine Osaka Prefecture University
スポンサーリンク
概要
関連著者
-
KIYOMIYA Ken-ichi
Department of Toxicology, School of Veterinary Medicine, University of Osaka Prefecture
-
MATSUO Saburo
Department of Toxicology, School of Veterinary Medicine, University of Osaka Prefecture
-
Kurebe Masaru
Department Of Toxicology School Of Veterinary Medicine Osaka Prefecture University
-
Kiyomiya Ken-ichi
Department Of Toxicology School Of Veterinary Medicine University Of Osaka Prefecture
-
Kiyomiya Ken-ichi
Department Of Toxicology School Of Veterinary Medicine Osaka Prefecture University
-
Matsuo Saburou
Department Of Toxicology School Of Veterinary Medicine Osaka Prefecture University
-
Matsuo Saburou
Department Of Toxicology School Of Veterinary Medicine University Of Osaka Prefecture
-
Tian Guanxun
Department Of Toxicology School Of Veterinary Medicine Osaka Prefecture University
-
Tian Guangxun
Department Of Toxicology School Of Veterinary Medicine Osaka Prefecture University
-
KIYOMIYA Ken-ichi
Department of Pharmacology, School of Pharmaceutical Sciences, Kitasato University
-
KUREBE Masaru
Department of Toxicology, School of Veterinary Medicine, Osaka Prefecture University
-
Matsuo Saburo
Department Of Toxicology School Of Veterinary Medicine Osaka Prefecture University
-
TIAN Guangxun
Department of Toxicology, School of Veterinary Medicine, University of Osaka Prefecture
-
Matsuo Saburou
Department of Toxicology, School of Veterinary Medicine, Osaka Prefecture University
-
Tian Guanxun
Department of Toxicology, School of Veterinary Medicine, Osaka Prefecture University
著作論文
- STUDY TO CLARIFY THE MECHANISM OF CYTOTOXIC ACTION OF ADRIAMYCIN, ANTICANCER AGENT : EXISTENCE OF CARRIER TO TRANSLOCATE ADRIAMYCIN FROM CYTOPLASM INTO NUCLEUS
- "P-64 The mechanism of specific nuclear transport of adriamycin, anticancer agent : The mode of nuclear translocation of adriamycin-proteasome complex.
- Contribution of the intracellular translocator to specific action of anthracycline anticancer agents, adriamycin and pirarubicin.